Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
7 studies found for:    Open Studies | "Kernicterus"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Condition: Smallpox
Intervention: Biological: MVA-BN® smallpox vaccine
2 Recruiting Determining Prevalence of Acute Bilirubin Encephalopathy in Developing Countries
Conditions: Demonstrate BIND II Score of >=5, is Valid for Detecting Moderate to Severe ABE in Neonates <14 Days Old.;   Demonstrate Community-BIND Instrument, a Modified BIND II, is a Valid and Reliable Tool for Detecting ABE.;   Demonstrate That Community-BIND Can be Used for Acquiring Population-based Prevalence of ABE in the Community.
Intervention: Other: Bilirubin Induced Neurologic Dysfunction II score
3 Recruiting Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)
Condition: Smallpox
Intervention:
4 Recruiting Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Condition: Smallpox
Intervention: Biological: ACAM2000® smallpox vaccine
5 Available Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Conditions: Smallpox;   Monkeypox
Intervention: Drug: Tecovirimat
6 Not yet recruiting A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®
Condition: 18-42 Year Old Healthy Vaccinia-naïve Subjects
Interventions: Biological: MVA BN®;   Biological: ACAM2000®
7 Recruiting ACAM2000® Myopericarditis Registry
Conditions: Myocarditis;   Pericarditis
Intervention:
To Top

† Indicates status has not been verified in more than two years